| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/02/2009 | EP2024338B1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments |
| 09/02/2009 | EP1965669B1 Composition comprising oligosaccharides as soluble dietary fibres for use against muscle wasting |
| 09/02/2009 | EP1957098B1 Management of non septic patients suffering from partial thickness burns by administration of activated protein c |
| 09/02/2009 | EP1937672B1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 09/02/2009 | EP1928448B1 ASSOCIATION OF ß3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC USE THEREOF |
| 09/02/2009 | EP1926705B1 Process for preparing valsartan |
| 09/02/2009 | EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 09/02/2009 | EP1904070A4 Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
| 09/02/2009 | EP1902037B1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 09/02/2009 | EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 09/02/2009 | EP1896019B1 Formulation of a thienopyridine platelet aggregation inhibitor |
| 09/02/2009 | EP1893630B1 Steroids having a mixed androgenic and progestagenic profile |
| 09/02/2009 | EP1891064B1 N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as ccr1 antagonists |
| 09/02/2009 | EP1888574B1 New antibiotic derivatives |
| 09/02/2009 | EP1856052B1 Nk1 antagonists |
| 09/02/2009 | EP1824502A4 Compositions comprising sclareol or derivatives thereof and uses thereof |
| 09/02/2009 | EP1807422B1 5-ht4 receptor agonist compounds |
| 09/02/2009 | EP1771440A4 Generic probes for the detection of phosphorylated sequences |
| 09/02/2009 | EP1761254B1 Improvement of image quality in the eye |
| 09/02/2009 | EP1758860B1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 09/02/2009 | EP1758852B1 Substituted cyclopentene compounds |
| 09/02/2009 | EP1744759B1 Use of loteprednol etabonate for the treatment of dry eye |
| 09/02/2009 | EP1719516B1 A pharmaceutical composition used for treating recurrent spontaneous abortion and method thereof |
| 09/02/2009 | EP1696932B1 Use of treprostinil to improve kidney functions |
| 09/02/2009 | EP1692097B1 Tricyclic hydroxamate and benzamide derivatives, compositions and methods |
| 09/02/2009 | EP1651648A4 Compounds and compositions as protein kinase inhibitors |
| 09/02/2009 | EP1641763B1 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 09/02/2009 | EP1601325B1 Antisense oligonucleotides that inhibit expression of hif-1 |
| 09/02/2009 | EP1585817B1 Conjugates comprising a biodegradable polymer and uses therefor |
| 09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/02/2009 | EP1523372B1 Ghrelin-carrier conjugates |
| 09/02/2009 | EP1496890B1 Substituted beta-aminoalcohols used as medicaments |
| 09/02/2009 | EP1478365B1 Combination consisting of trapidil and 5ht2-serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis |
| 09/02/2009 | EP1472259B1 Tetrapyrrolic macrocycles as photodynamic agents |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1448587B1 Noonan syndrome gene |
| 09/02/2009 | EP1432718B1 Phosphor containing compounds with antithrombitic activity |
| 09/02/2009 | EP1423115B9 Antiangiogenic activity of nitrogen substituted thalidomide analogs |
| 09/02/2009 | EP1418925A4 Bioabsorbable adhesive compunds and compositions |
| 09/02/2009 | EP1411913A4 Antimicrobial nanoemulsion compositions and methods |
| 09/02/2009 | EP1374863B1 Amino acid compositions for ameliorating liver failure |
| 09/02/2009 | EP1366081B1 Grain fractionation methods and products |
| 09/02/2009 | EP1353663B1 Fenofibrate tablets |
| 09/02/2009 | EP1309333B1 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 09/02/2009 | EP1300395B1 4-substituted piperidine compound |
| 09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
| 09/02/2009 | EP1282443B1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
| 09/02/2009 | EP1261254B1 Method of controlling zoological and aquatic plant growth |
| 09/02/2009 | EP1228125A4 Process for making aqueous coated beadlets |
| 09/02/2009 | EP0995448B1 Compound for diagnosing malignant tumors |
| 09/02/2009 | CN101522266A Topical skin compositions, their preparation, and their use |
| 09/02/2009 | CN101522265A Topical skin compositions, their preparation and their use |
| 09/02/2009 | CN101522202A Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of SIRNA |
| 09/02/2009 | CN101522201A Solid citrate and tartrate salts of DPP-IV inhibitors |
| 09/02/2009 | CN101522200A Topical formulations of borinic acid antibodies and their methods of use |
| 09/02/2009 | CN101522199A Novel method of treatment of male sub-fertility |
| 09/02/2009 | CN101522198A Pharmaceutical formulation for the treatment of complaints |
| 09/02/2009 | CN101522197A Urotensin II receptor antagonists |
| 09/02/2009 | CN101522196A Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
| 09/02/2009 | CN101522195A Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 09/02/2009 | CN101522194A Prophylactic/therapeutic agent for renal dysfunction |
| 09/02/2009 | CN101522193A Compositions for reducing nicotine withdrawal symptoms and/or tobacco usage |
| 09/02/2009 | CN101522192A Substituted imidazolone derivatives, preparation and uses |
| 09/02/2009 | CN101522191A Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 09/02/2009 | CN101522190A Pyrrolidinone anilines as progesterone receptor modulators |
| 09/02/2009 | CN101522189A Polymorphic form of duloxetine hydrochloride |
| 09/02/2009 | CN101522188A 抗癌剂 Anticancer agent |
| 09/02/2009 | CN101522187A Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
| 09/02/2009 | CN101522186A Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 09/02/2009 | CN101522185A Antidepressant agent |
| 09/02/2009 | CN101522184A Thiourea compounds |
| 09/02/2009 | CN101522183A Pharmaceutical composition for prevention and/or treatment of bone disease, functional food or health food comprising the composition, and pharmaceutical preparation comprising the composition as acti |
| 09/02/2009 | CN101522182A Olive juice extracts for promoting muscle health |
| 09/02/2009 | CN101522181A Use of hypothermia inducing drugs to treat ischemia |
| 09/02/2009 | CN101522180A Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
| 09/02/2009 | CN101522179A Enhanced broad-spectrum UV radiation filters and methods |
| 09/02/2009 | CN101519424A Acanthopanaxgenin acid with antitumor and antiangiogenic activities |
| 09/02/2009 | CN101519423A Betulinic acid analogue and preparation method and application thereof |
| 09/02/2009 | CN101519421A Method for preparing high-purity demethylzelasteral |
| 09/02/2009 | CN101519410A Preparation method for metallic thiophene ring ternary complex with anti-cancer activity and application thereof |
| 09/02/2009 | CN101519404A 15-cyclothiaketone derivative, preparation method and application thereof |
| 09/02/2009 | CN101519402A Thiochromone compound, synthetic method and application thereof in preparing antifungal medicaments |
| 09/02/2009 | CN101519394A 3-aryl-coumarin derivatives and preparation method and application thereof |
| 09/02/2009 | CN101519392A Compound treating diabetes and relevant complicating diseases and preparation method and application thereof |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101519385A Small molecule compound being capable of promoting proliferation of stem cells and function thereof |
| 09/02/2009 | CN101519378A Diaryl pyrimidyl guanidine and preparation method and pharmaceutical use of same |
| 09/02/2009 | CN101519375A Antifungal pyrazoline-substituting compound and preparation method and application thereof |
| 09/02/2009 | CN101519372A Benzo [e] isoindazole-1,3 diketone compound used as GSK inhibiting agent and preparation method thereof |
| 09/02/2009 | CN101519368A Small molecule entry inhibitors |
| 09/02/2009 | CN101519363A Substituted naphthylalanine derivative used as protein tyrosine phosphatase 1B (PTP1B) inhibitor |
| 09/02/2009 | CN101519345A Trans-3,5-dihydroxyl-4'-bromo butoxyl toluylene as well as preparation and application thereof |
| 09/02/2009 | CN101518654A Method for synthesizing novel preparation capable of carrying glucocorticoid to be used as inflammation targeted drug |
| 09/02/2009 | CN101518653A Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 09/02/2009 | CN101518652A Preparation method of toltrazuril-cyclodextrin inclusion compound |
| 09/02/2009 | CN101518651A Pastille slow-release material and preparation method and application thereof |
| 09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 09/02/2009 | CN101518649A Compound preparation for treating ophthalmic infection and inflammation |